Drug Injury Watch

Drug Injury Watch provides developing information about prescription drug side effects as well as up-to-date news from the legal, medical, FDA, and pharmaceutical sectors. Tom Lamb's articles add insight from a drug litigation attorney perspective, but are written to be read by consumers and others.

Author: Tom Lamb practices in Wilmington, N.C., and represents patients in drug injury cases.

Blawg Related Categories: Government Law • Product Liability Law • Solo / Small Firm

Recent Posts from Drug Injury Watch

Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease
TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) The anemia drug Aranesp (darbepoetin alfa) might cause an…
Diabetes Drug Byetta Linked To Kidney Problems And Cases Of Renal Failure
October 2009 Byetta Label Change Follows Earlier Alert From U.K. About Kidney-Related Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2009 the Drug Safety Update Newsletter alerted us about reports of kidney-related side…
FDA Should Make Drug Efficacy And Safety Information More Accessible To Patients
Package Inserts Prepared By Drug Companies Which Exagerrate Benefits And Downplay Risks Need To Be Addressed (Posted by Tom Lamb at DrugInjuryWatch.com) In the October 21, 2009 edition of The New England Journal of Medicine…
Yasmin And Yaz Birth Control Pills Are Under Scrutiny By Drug Regulators In Europe
Bayer Confirms To German Newspaper There Are 129 Yasmin / Yaz Lawsuits In U.S. As Of Mid-October 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) From an October 21, 2009 article, "Bayer under pressure as birth…
First Zometa-ONJ Personal Injury Lawsuit Against Novartis Goes To Jury This Week
Montana Woman's Case Is First To Trial; More Than 500 Other Jaw Side Effect Cases Filed In Federal MDL And New Jersey Courts (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: "Missoula woman awarded $3.2M…
FDA’s Sentinel Initiative Project: An Overview, Progress To Date, And Next Steps
Presentation Made At September 17, 2009 FDA Drug Safety Oversight Board Meeting (Posted by Tom Lamb at DrugInjuryWatch.com) At the September 17, 2009 meeting of the FDA Drug Safety Oversight Board (DSB), members heard presentations…
A Review Of Recent Research On Issue Of Whether Januvia Can Cause Pancreatitis
Is Pancreatitis A Januvia Side Effect Or Is There An Increased Risk Of This Medical Condition Among Type 2 Diabetics Across All Treatments (Posted by Tom Lamb at DrugInjuryWatch.com) A few weeks back we reported…
Waiting For The Results From Swissmedic Safety Analysis Of Yaz And Other Drospirenone-Containing Contraceptives
Prompted By Investigation Into Death Of Young Woman Who Died While Using Yaz; Results Of Analysis Expected In Late October 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) In late September 2009 we learned that the…
FDA Transparency Task Force Will Hold Its Second Public Meeting On November 3, 2009
Emerging Safety Issues Concerning FDA-Regulated Products Is One Issue For Discussion Listed in October 2009 Federal Register Notice (Posted by Tom Lamb at DrugInjuryWatch.com) In the Federal Register for October 5, 2009 the FDA gave…
October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court
MDL No. 2100 -- IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation -- Assigned To Southern District of Illinois (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Our Focus…